Biotech · Private company · Burlingame, CA, US

Aeton Therapeutics, Inc.

Track this companyFree. Adds Aeton Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards2

Human CGAS inhibitors to treat neurodegeneration in Alzheimer's diseaseFiscal year 2026 · $932.7KNIH RePORTER 1R44AG099654-01 · fetched Nov 12, 2026
Acetylated Tau Immunotherapy for Alzheimer's DiseaseFiscal year 2024 · $499.9KNIH RePORTER 1R41AG085770-01 · fetched Nov 12, 2026